Eli Lilly and Co (LLY)

82.87
NYSE : Health Care
Prev Close 82.55
Day Low/High 82.24 / 83.24
52 Wk Low/High 64.18 / 83.78
Avg Volume 5.28M
Exchange NYSE
Shares Outstanding 1.10B
Market Cap 91.08B
EPS 2.60
P/E Ratio 32.00
Div & Yield 2.08 (2.50%)

Latest News

Execs from Boeing, Pfizer Send Letter Backing House GOP Tax Plan

Execs from Boeing, Pfizer Send Letter Backing House GOP Tax Plan

Executives from 16 companies, including Boeing, Oracle and Pfizer, are weighing in to support the increasingly-contentious border adjustment tax

Procter & Gamble, Apple, Home Depot: Doug Kass' Views

Procter & Gamble, Apple, Home Depot: Doug Kass' Views

Doug Kass shares his thoughts on Procter & Gamble, and wonders if the market is about to slip its moorings.

Clovis, Tesaro Soar on Astrazeneca Phase Three News

Clovis, Tesaro Soar on Astrazeneca Phase Three News

AstraZeneca shares, meanwhile, were less-than-moved by the news.

Snapchat's Parent Prices IPO at Low End of Expectations

Snapchat's Parent Prices IPO at Low End of Expectations

Snap Inc. is preparing for the biggest technology IPO since Alibaba in 2014.

DexCom Is a Great Healthcare Stock to Buy Now

DexCom Is a Great Healthcare Stock to Buy Now

The continuous glucose monitor maker is an excellent growth opportunity.

Eli Lilly Is Great Stock to Buy Now

Eli Lilly Is Great Stock to Buy Now

Here's why the pharmaceutical company is a solid addition to your portfolio.

Here's How the Tom Price Stock Portfolio Is Performing Now That He Is Confirmed

Here's How the Tom Price Stock Portfolio Is Performing Now That He Is Confirmed

Tom Price will now head the Department of Health and Human Services.

Dividend Hikes and Must-Own Dates

Interpublic and United Parcel raise dividends, and a recap of notable dates.

Biotech Tesaro Climbs on Takeout Reports

Biotech Tesaro Climbs on Takeout Reports

The company's shares were up 14% on rumors that it is working with investment banks to consider a sale.

Cramer: Allergan Is the New Pharma Growth Stock

Cramer: Allergan Is the New Pharma Growth Stock

Jim Cramer compares Allergan's growth to other pharma stocks.

New Research Reveals Powerful Health Benefits Of Dog Companionship

New Research Reveals Powerful Health Benefits Of Dog Companionship

Service-dog Study Shows Benefits to Emotional Well-being for Owners

Pfizer CEO: 'Misinformation About Drug Pricing Is Far Greater Than I've Ever Seen'

Pfizer CEO: 'Misinformation About Drug Pricing Is Far Greater Than I've Ever Seen'

The pharma giant will lever up should a strategic deal opportunity come along, too.

Wall Street Ends January on Weak Note as Washington Division Deepens

Wall Street Ends January on Weak Note as Washington Division Deepens

It's day 12 in Trump's America and the shine of an outsider presidency has already worn off.

Dow Is On Track for Worst Day of 2017 Amid Trump White House Uncertainty

Dow Is On Track for Worst Day of 2017 Amid Trump White House Uncertainty

Deep political and civic division over recent executive actions from the White House continue to make market waves on Tuesday.

Cramer: Trump's Carrot-Stick Approach Doesn't Make Pharma Any More Attractive

Cramer: Trump's Carrot-Stick Approach Doesn't Make Pharma Any More Attractive

Two industries should largely be avoided under this administration: pharma and retail.

Eli Lilly Confirms Guidance for 2017, CEO Meets With Trump

Eli Lilly Confirms Guidance for 2017, CEO Meets With Trump

Eli Lilly reaffirms its 2017 guidance after reporting higher sales and earnings in its latest quarter.

S&P 500 Falls for a Fourth Day as 'Rose-Tinted Glasses' of Trump Presidency Come Off

S&P 500 Falls for a Fourth Day as 'Rose-Tinted Glasses' of Trump Presidency Come Off

Uncertainty surrounding an immigration ban on a number of Muslim-majority countries continues to fuel volatility on markets on Tuesday.

Lilly Earnings Guidance for 2017 Remains Unchanged

Lilly Earnings Guidance for 2017 Remains Unchanged

Eli Lilly CEO David Ricks is joining a group of drug industry executives meeting with President Donald Trump on Tuesday.

5 Things You Must Know Before the Market Opens Tuesday

5 Things You Must Know Before the Market Opens Tuesday

U.S. stock futures point lower Tuesday on continued concerns over Donald Trump's travel ban.

Market Recon: Political Risk Shows Signs of Becoming Ongoing Condition

Market Recon: Political Risk Shows Signs of Becoming Ongoing Condition

You are going to have to defend your book, if you have not already.

Jaguar Animal Health, Elanco Enter Global Collaboration For Development, Co-Promotion Of Canalevia

Jaguar Animal Health, Elanco Enter Global Collaboration For Development, Co-Promotion Of Canalevia

Jaguar Animal Health, Inc. (NASDAQ: JAGX) and Elanco US Inc.

Market Recon: This Is What Political Risk Looks Like

Market Recon: This Is What Political Risk Looks Like

Anything that slows down or distracts from a pro-business agenda would clearly be a risk.